Voyager Therapeutics (VYGR) PT Lowered to $8 at Wedbush
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St futures muted as oil gains curb risk appetite after S&P record close
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Voyager Therapeutics (VYGR) Tops Q1 EPS by 24c, provides guidance
May 13, 2024 4:23 PM EDTVoyager Therapeutics (NASDAQ: VYGR) reported Q1 EPS of ($0.20), $0.24 better than the analyst estimate of ($0.44). Revenue for the quarter came in at $19.5 million versus the consensus estimate of $9.42 million.
Financial Guidance
Voyager is committed to maintaining a strong balance sheet that... More
